- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about HCM
Recent news which mentions HCM
From Benzinga
From Benzinga
Which Chinese Stocks Will Be Delisted? 8 in U.S. Crosshairs
March 28, 2022
From InvestorPlace
From InvestorPlace
From Motley Fool
From Benzinga
Chinese Stock Delisting News: Why Are BABA, DIDI, IQ, YUMC, ACMR, BGNE and ZLAB Down Today?
March 11, 2022
From InvestorPlace
What's Going On With Zai Lab, Hutchmed, BeiGene Shares Today
March 11, 2022
From Benzinga
From Benzinga
From MarketWatch
Chinese Stocks Are Falling: What's Going On?
March 10, 2022
From Benzinga
From MarketWatch
Hutchmed Clocks Over 50% Jump In FY21 Sales Boosted By Three Oncology Drugs, Announces CEO Transition
March 03, 2022
Tickers
HCM
From Benzinga
Earnings Scheduled For March 3, 2022
March 03, 2022
From Benzinga
58 Biggest Movers From Yesterday
December 17, 2021
From Benzinga
31 Stocks Moving In Thursday's Mid-Day Session
December 16, 2021
From Benzinga
18 Stocks Moving in Thursday's Pre-Market Session
December 16, 2021
From Benzinga
61 Biggest Movers From Yesterday
November 23, 2021
From Benzinga
40 Stocks Moving In Monday's Mid-Day Session
November 22, 2021
From Benzinga
20 Stocks Moving in Monday's Pre-Market Session
November 22, 2021
From Benzinga
Big Pharma Is Going Holiday Shopping. Who's Next?
November 10, 2021
From Motley Fool
HUTCHMED's Lymphoma Candidate Secures Breakthrough Tag In China
September 13, 2021
Tickers
HCM
From Benzinga
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
September 08, 2021
From Benzinga
Epizyme Stock Gains On Potential $310M Pact With HUTCHMED For Cancer-Focused Tazverik In Greater China
August 09, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
July 29, 2021
From Benzinga
62 Biggest Movers From Yesterday
July 29, 2021
From Benzinga
Tickers
HCM
From Motley Fool
50 Stocks Moving In Wednesday's Mid-Day Session
July 28, 2021
From Benzinga
From Benzinga
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.